2025 Summer Associate Wade Marshall contributed to this article.
Recently, two Northern District of California decisions revealed fault lines in the forming fair use terrain for GenAI copyright infringement actions. Both...more
Some of the largest movie studios have entered the fray of GenAI copyright litigation. Disney, Marvel, Lucasfilm, Twentieth Century Fox, Universal Pictures, and DreamWorks sued the image-GenAI company Midjourney, Inc. in the...more
6/16/2025
/ Artificial Intelligence ,
Copyright Infringement ,
Copyright Litigation ,
Damages ,
Entertainment Industry ,
Fair Use ,
Film Industry ,
Intellectual Property Litigation ,
Machine Learning ,
Plagiarism ,
The Copyright Act ,
Willful Infringement
Sterne Kessler’s U.S. IP Update is a newsletter delivering the latest developments in U.S. intellectual property law, tailored for companies and legal counsel in Korea. Stay informed on key court decisions, policy changes,...more
5/22/2025
/ Alice/Mayo ,
Artificial Intelligence ,
FRAND ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
IP License ,
Machine Learning ,
Patent Litigation ,
Patents ,
Software ,
Standard Essential Patents ,
Unified Patent Court
On Friday, April 18, 2025, the Federal Circuit addressed a question of first impression regarding the validity of certain machine-learning patents under Section 101 in Recentive Analytics, Inc. v. Fox Corp., et al.,...more
On Tuesday, February 11, a Delaware district court issued much-awaited summary-judgment decisions in Thomson Reuters Enterprise Centre GmbH et al v. ROSS Intelligence Inc., No. 1:20-cv-613, potentially shaping how future...more
2/13/2025
/ Algorithms ,
Andy Warhol Foundation for the Visual Arts Inc v Goldsmith ,
Artificial Intelligence ,
Copyright ,
Copyright Infringement ,
Copyright Litigation ,
Fair Use ,
Intellectual Property Protection ,
Legal Technology ,
Machine Learning ,
Summary Judgment ,
Technology Sector
FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support a regulatory decision about a drug or biological product’s safety, effectiveness, or...more
1/15/2025
/ Artificial Intelligence ,
Biologics ,
Data Management ,
Draft Guidance ,
Filing Requirements ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Machine Learning ,
Medical Devices ,
Pharmaceutical Industry ,
Popular ,
Public Comment ,
Regulatory Requirements ,
Risk Management